Adm1n: Created page with "PF-03550096 is a drug that acts as a potent agonist for the CB2 cannabinoid receptor, with good selectivity over CB1 having Ki values of 7nM at CB2 and 1500nM at CB1...."

2015-02-15T02:16:53Z

Created page with "PF-03550096 is a drug that acts as a potent agonist for the CB2 cannabinoid receptor, with good selectivity over CB1 having Ki values of 7nM at CB2 and 1500nM at CB1...."

New page

PF-03550096 is a drug that acts as a potent agonist for the [[CB2]] cannabinoid receptor, with good selectivity over [[CB1]] having Ki values of 7nM at CB2 and 1500nM at CB1. It was originally developed by Pfizer in 2008 as a medication for irritable bowel syndrome, but has only progressed to animal studies.

==See also==

* [[AB-FUBINACA]]
* [[AB-PINACA]]

PF-03550096 - Revision history

Adm1n: Created page with "PF-03550096 is a drug that acts as a potent agonist for the CB2 cannabinoid receptor, with good selectivity over CB1 having Ki values of 7nM at CB2 and 1500nM at CB1...."